For instance, although PLVAP–GPC3 showed optimal performance in HCC, PLVAP shows limitedspecificity, with comparable levels detected in the lung, kidney, and heart (Fig. 2E-ii), making it an unfavorable pair, asillustrated in Fig. 2A. The gene discussed is GPC3; the disease is hepatocellular carcinoma.